Learn how to use LillyDirect to access the GLP-1s Zepbound and Foundayo, and decide whether LillyDirect, telehealth or another pharmacy route fits your needs.
Adults taking tirzepatide injection in a clinical trial lost on average 21.8 kg (48 lbs.) at the highest dose TORONTO, July 9, 2025 /CNW/ - Eli Lilly Canada is pleased to announce that ZEPBOUND™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results